HK Bio-Med Innotech Association
is committed to establish an innovative and
international biomedical technology hub in Hong Kong

Actively introduce excellent bio-pharmaceutical innovation technology projects from overseas and provide assistance in various aspects, including fund raising, R&D technology, patent protection, regulations, valuation, clinical trial design and planning, contract development manufacture, project commercialization, etc. to enter the Mainland China and Asia market

Cross-Strait Bio-Med Innotech Alliance

The Alliance is co-founded by HK-Bio Med Innotech Association, China Pharmaceutical Innovation and Research Development Association (PhIRDA), Institute for Biotechnology and Medicine Industry (IBMI), and International Association of Quality Research in Chinese Medicine.


The goal is to create a bio-pharmaceutical innovation and cooperation platform, which will establish a platform for joint scientific and technological innovation talent in HK, Mainland China, Taiwan and Macau, promoting regulatory convergence of international standards, accelerating the sharing of the four pharmaceutical markets, and achieving the effective deployment of capital markets. It will aim to develop itself into a collaborative channel for Asian and all overseas Chinese in global biomedical industry.